Neoadjuvant chemoradiotherapy is the standard treatment for locally advanced rectal cancer. Patients with pathological complete response (pCR) after NCRT (15~21% of the total) could benefit from either less invasive surgery or a “wait-and-see” strategy. A radiomics model is proposed in this work based on diffusion kurtosis imaging (DKI) result before NCRT is used to predict pCR of rectal cancer.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords